Home › Trial NCT03120832
Phase 1 Trial of PAN-301-1 (SNS-301) in Cancer Patients
- Trial IDNCT03120832
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorSensei Biotherapeutics, Inc.
- Enrollment12
- Start date2016-12
- ConditionsProstate Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.